1. The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoSphere study. (April 2018) Authors: Triulzi, T.; Di Cosimo, S.; Bianchini, G.; Pienkowski, T.; Im, Y.H.; Bianchi, G.V.; De Cecco, L.; Tseng, L.M.; Liu, M.C.; Lluch, A.; Semiglazov, V.; De la Haba-Rodriguez, J.; Oh, D.Y.; Poirier, B.; Pedrini, J.L.; Valagussa, P.; Tagliabue, E.; Gianni, L. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗